Molecular Mechanism of Autophagy in Cancer Immune Escape
Immunotherapies appear to give some promising clinical outcomes in patients with advanced and metastatic cancer that are ... highlighted in tumor immunity. Autophagy appears to regulate the immune ...
read more

UCLA researchers advance cancer treatment aiming to target tumors
UCLA researchers developed a new cancer treatment that could be useful for targeting solid tumors. In the study, the researchers said they developed a biodegradable scaffold that is implanted near ...
read more
IO Biotech Provides Business Update
NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® vaccine ...
read more
Characterization of Ikaros zinc finger protein 1 mutations in acute myeloid leukemia
Researchers evaluated the clinical and genetic characteristics of acute myeloid leukemia (AML) patients with a mutant Ikaros zinc finger protein 1 (IKZF1).
read more

IO Biotech Provides Business Update
NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® vaccine ...
read more
Bacteria play specific roles in cancer
In a recent article published in the journal Immunity, the authors discussed the findings from a 2022 study by Galeano Niño et al., which reported that microbiota associated with tumors form ...
read more
The role of gut microbiota in cancer treatment: friend or foe?
cuhk.edu.hk The gut microbiota has been implicated in cancer and shown to modulate anticancer drug efficacy. Altered gut microbiota is associated with resistance to chemo drugs or immune checkpoint ...
read more
IO Biotech Provides Business Update
The level of enthusiasm from leading cancer institutions around the world to work with our novel, investigational immune-modulating vaccine we believe is a testament to the potential broad ...
read more
IO Biotech Announces Appointment of Devin Smith as General Counsel
Mr. Smith joins IO Biotech bringing over two decades of legal and compliance experience in the life science industriesNEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a ...
read more
AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
dostarlimab plus chemotherapy is in the pivotal COSTAR Lung Phase 3 trial in advanced non-small cell lung cancer in patients who have progressed ... It is developing immune cell modulating antibodies, ...
read more
Related Blogs:
Cancer Immune Biotech Modulating Clinical Vaccine Developing Microbiota Newswire Patients Researchers Nasdaq Immune Modulating Biotech Nasdaq Globe Newswire